These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33196522)

  • 1. Dose Assessment Following a 238Pu-contaminated Wound Case with Chelation and Excision.
    Poudel D; Klumpp JA; Bertelli L; Dumit S; Waters TL
    Health Phys; 2020 Dec; 119(6):690-703. PubMed ID: 33196522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a New Chelation Model: Bioassay Data Interpretation and Dose Assessment after Plutonium Intake via Wound and Treatment with DTPA.
    Dumit S; Miller G; Klumpp JA; Poudel D; Bertelli L; Waters TL
    Health Phys; 2020 Dec; 119(6):715-732. PubMed ID: 33196524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of a puncture wound case with medical intervention.
    Bailey BR; Eckerman KF; Townsend LW
    Radiat Prot Dosimetry; 2003; 105(1-4):509-12. PubMed ID: 14527019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating Plutonium Intake and Radiation Dose Following Extensive Chelation Treatment.
    Dumit S; Avtandilashvili M; Tolmachev SY
    Health Phys; 2019 Aug; 117(2):156-167. PubMed ID: 29750674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interpretation of Urinary Excretion Data From Plutonium Wound Cases Treated With DTPA: Application of Different Models and Approaches.
    Poudel D; Bertelli L; Klumpp JA; Waters TL
    Health Phys; 2017 Jul; 113(1):30-40. PubMed ID: 28542009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid Response, Dose Assessment, and Clinical Management of a Plutonium-contaminated Puncture Wound.
    Sugarman SL; Findley WM; Toohey RE; Dainiak N
    Health Phys; 2018 Jul; 115(1):57-64. PubMed ID: 29787431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some Considerations for Chelation Treatment and Surgical Excision Following Incorporation of Plutonium in Wounds.
    Poudel D; Bertelli L; Klumpp JA; Waters TL
    Health Phys; 2018 Mar; 114(3):307-318. PubMed ID: 29360709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling of bioassay data from a Pu wound treated by repeated DTPA perfusions: biokinetics and dosimetric approaches.
    Fritsch P; Grappin L; Guillermin AM; Fottorino R; Ruffin M; Mièle A
    Radiat Prot Dosimetry; 2007; 127(1-4):120-4. PubMed ID: 17562647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-four years of follow-up for a Hanford plutonium wound case.
    Carbaugh EH; Lynch TP; Antonio CL; Medina-Del Valle F
    Health Phys; 2010 Oct; 99(4):483-94. PubMed ID: 20838089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to a Skin Puncture Contaminated with 238Pu at Los Alamos National Laboratory.
    Klumpp J; Bertelli L; Dumit S; Gadd M; Poudel D; Waters TL
    Health Phys; 2020 Dec; 119(6):704-714. PubMed ID: 33196523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chelation Modeling: The Use of Ad Hoc Models and Approaches to Overcome a Dose Assessment Challenge.
    Dumit S; Bertelli L; Klumpp JA; Poudel D; Waters TL
    Health Phys; 2020 Feb; 118(2):193-205. PubMed ID: 31833972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Modeling of Plutonium-DTPA Decorporation.
    Dumit S; Avtandilashvili M; Strom DJ; McComish SL; Tabatadze G; Tolmachev SY
    Radiat Res; 2019 Feb; 191(2):201-210. PubMed ID: 30566387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of multi-compartment wound models to plutonium-contaminated wounds incurred by former workers at rocky flats.
    Falk RB; Daugherty NM; Aldrich JM; Furman FJ; Hilmas DE
    Health Phys; 2006 Aug; 91(2):128-43. PubMed ID: 16832194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plutonium-DTPA Model Application with USTUR Case 0269.
    Konzen K; Brey R; Miller S
    Health Phys; 2016 Jan; 110(1):59-65. PubMed ID: 26606066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three plutonium chelation cases at Los Alamos National Laboratory.
    Bertelli L; Waters TL; Miller G; Gadd MS; Eaton MC; Guilmette RA
    Health Phys; 2010 Oct; 99(4):532-8. PubMed ID: 20838095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of 3,4,3-LI(1,2-HOPO) for decorporation of Pu, Am and U from rats injected intramuscularly with high-fired particles of MOX.
    Paquet F; Chazel V; Houpert P; Guilmette R; Muggenburg B
    Radiat Prot Dosimetry; 2003; 105(1-4):521-5. PubMed ID: 14535232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a system of models for plutonium decorporation therapy.
    Dumit S; Avtandilashvili M; McComish SL; Strom DJ; Tabatadze G; Tolmachev SY
    Radiat Environ Biophys; 2019 May; 58(2):227-235. PubMed ID: 30627772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chelation Modeling of a Plutonium-238 Inhalation Incident Treated with Delayed DTPA.
    Dumit S; Miller G; Grémy O; Poudel D; Bertelli L; Klumpp JA
    Radiat Res; 2023 Dec; 200(6):577-586. PubMed ID: 37956868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined drug and surgery treatment of plutonium-contaminated wounds: indications obtained using a rodent model.
    Griffiths NM; Coudert S; Wilk JC; Renault D; Angulo JF; Van der Meeren A
    Health Phys; 2014 Jun; 106(6):638-44. PubMed ID: 24776894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing a physiologically based approach for modeling plutonium decorporation therapy with DTPA.
    Kastl M; Giussani A; Blanchardon E; Breustedt B; Fritsch P; Hoeschen C; Lopez MA
    Int J Radiat Biol; 2014 Nov; 90(11):1062-7. PubMed ID: 24844369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.